返回
Automated deep brain stimulation programming based on electrode location: a randomised, crossover trial using a data-driven algorithm
DOI:10.1016/S2589-7500(22)00214-X.png)
摘要
En 中文
Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is highly effective in controlling motor symptoms in patients with Parkinson's disease. However, correct selection of stimulation parameters is pivotal to treatment success and currently follows a time-consuming and demanding trial-and-error process. We aimed to assess treatment effects of stimulation parameters suggested by a recently published algorithm (StimFit) based on neuroimaging data. Methods This double-blind, randomised, crossover, non-inferiority trial was carried out at Charite - Universitatsmedizin, Berlin, Germany, and enrolled patients with Parkinson's disease treated with directional octopolar electrodes targeted at the STN. All patients had undergone DBS programming according to our centre's standard of care (SoC) treatment before study recruitment. Based on perioperative imaging data, DBS electrodes were reconstructed and StimFit was applied to suggest optimal stimulation settings. Patients underwent motor assessments using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale part III (MDS-UPDRS-III) during OFF-medication and in OFF-stimulation and ON-stimulation states under both conditions, StimFit and SoC parameter settings. Patients were randomly assigned (1:1) to receive either StimFit-programmed DBS first and SoCprogrammed DBS second, or SoC-programmed DBS first and StimFit-programmed DBS second. The allocation schedule was generated using a computerised random number generator. Both the rater and patients were masked to the sequence of SoC and StimFit stimulation conditions. All patients who participated in the study were included in the analysis. The primary endpoint of this study was the absolute mean difference between MDS-UPDRS-III scores under StimFit and SoC stimulation, with a non-inferiority margin of 5 points. The study was registered at the German Register for Clinical Trials (DRKS00023115), and is complete.Findings Between July 10, 2020, and Oct 28, 2021, 35 patients were enrolled in the study; 18 received StimFit followed by SoC stimulation, and 17 received SoC followed by StimFit stimulation. Mean MDS-UPDRS-III scores improved from 47 & BULL;3 (SD 17 & BULL;1) at OFF-stimulation baseline to 24 & BULL;7 (SD 12 & BULL;4) and 26 & BULL;3 (SD 12 & BULL;4) under SoC and StimFit stimulation, respectively. Mean difference between motor scores was -1 & BULL;6 (SD 7 & BULL;1; 95% CI -4 & BULL;0 to 0 & BULL;9; superiority test psuperiority=0 & BULL;20; n=35), establishing non-inferiority of StimFit stimulation at a margin of -5 points (non-inferiority test pnon-inferiority=0 & BULL;0038). In six patients (17%), initial programming of StimFit settings resulted in acute side-effects and amplitudes were reduced until side-effects disappeared.Interpretation Automated data-driven algorithms can predict stimulation parameters that lead to motor symptom control comparable to SoC treatment. This approach could significantly decrease the time necessary to obtain optimal treatment parameters.
Keyword:
PARKINSONS-DISEASE
SUBTHALAMIC NUCLEUS
DOUBLE-BLIND
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
24.1
论文数:
1.2K
被引数:
8.5K
机构
引用论文
Minimal clinically important change on the Unified Parkinson's Disease Rating Scale统一帕金森病评分量表的最小临床重要变化
MOVEMENT DISORDERS
IF7.6
Multi-objective data-driven optimization for improving deep brain stimulation in Parkinson's disease多目标数据驱动优化改善帕金森病脑深部电刺激
Probabilistic mapping of the antidystonic effect of pallidal neurostimulation: a multicentre imaging study
BRAIN
IF11.7
Imaging-based programming of subthalamic nucleus deep brain stimulation in Parkinson's disease帕金森病丘脑底核深部脑刺激的基于成像的编程
BRAIN STIMULATION
IF8.4
Connectivity Predicts Deep Brain Stimulation Outcome in Parkinson Disease连通性预测帕金森病的深部脑刺激结果
ANNALS OF NEUROLOGY
IF7.7
StimVision v2: Examples and Applications in Subthalamic Deep Brain Stimulation for Parkinson's Disease
NEUROMODULATION
IF3.5

